Related Experiment Video
Updated: Jun 4, 2025

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
Atrial arrhythmias in patients beyond 40 Years of age post atrial septal defect device closure
Rui Lun Ng1, Boekhren Karyostyko1, Mohd Nor Hisham Ramli1
1Paediatric & Congenital Heart Centre, Institut Jantung Negara (National Heart Institute of Malaysia), Kuala Lumpur, Malaysia.
Insights
De novo atrial arrhythmia is uncommon after transcatheter closure of atrial septal defects (ASDs) in patients over 40. This study found a low incidence of new-onset arrhythmias post-procedure.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- Patients over 40 with atrial septal defects (ASDs) often experience atrial arrhythmias requiring treatment.
- The necessity of simultaneous left atrial appendage (LAA) occlusion during ASD closure remains unclear.
Purpose of the Study:
- To investigate the incidence of de novo atrial arrhythmia following transcatheter closure of ASDs in patients older than 40 years.
Main Methods:
- A single-center, retrospective study included consecutive patients over 40 undergoing device closure of ASDs.
- Standard 12-lead ECGs and ambulatory monitoring were utilized for pre- and post-procedure assessment.
Main Results:
- Eighty-eight patients were followed for a median of 3.6 years. Seven patients (8%) had pre-existing atrial arrhythmia (AA).
- Two patients (2.5%) developed de novo atrial fibrillation, and one (1.2%) developed ectopic atrial rhythm.
- Univariate analysis identified several risk factors, but none were significant in multivariate analysis for AA development.
Conclusions:
- The occurrence of de novo atrial arrhythmia after device closure for ASD in adults is infrequent.
- Further research may clarify risk factors and optimal management strategies.
Background:
Patients >40 years with an atrial septal defect (ASD) may have atrial arrhythmia which warrants treatment. It is unclear whether preventive left atrial appendage (LAA) occlusion should be performed simultaneously during ASD closure in these patients.
Objective:
This study aimed to examine the incidence of de novo atrial arrhythmia in patients >40 years old post transcatheter closure of ASD.
Methods:
This was a single-center, retrospective study involving all consecutive patients who have undergone device closure of ASDs at age >40 years. Standard 12-lead ECGs were performed pre-procedure and during every clinic follow-up. Ambulatory monitors were applied when indicated.
Results:
Eighty-eight patients (mean age: 51.81 ± 8.01 years; male: 22.7%) were recruited and followed up over a median duration of 3.6 years (range: 1-6.5). Seven patients (8%) had documented atrial arrhythmia (AA) pre and post ASD closure. Two patients (2.5%) developed de novo atrial fibrillation and one patient (1.2%), ectopic atrial rhythm during follow-up. In univariate analyses, age >61.3 years (p < 0.001), a history of palpitation (p = 0.006), right atrial area >25.15cm2 pre-closure (p = 0.004); dilated right and left atrium immediately post ASD closure (p = 0.016 & 0.001) and pulmonary vascular resistance >1.31Woods unit (p = 0.036) were associated with increased risk of AA. However, on multivariate analyses, none were significantly associated with AA.
Conclusions:
De novo atrial arrhythmia after ASD device closure is uncommon.
More Related Videos
Related Concept Videos
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Mechanism of Cardiac Arrhythmias
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

